Literature DB >> 7673401

Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children.

M Boguszewski1, S Rosberg, K Albertsson-Wikland.   

Abstract

To evaluate spontaneous GH secretion in terms of both secretory rate and pulsatile pattern in prepubertal children born small for gestational age (SGA) and still short (below -2 SD scores) at or after 2 yr of age, 24-h GH profiles were investigated in 106 such patients (75 boys and 31 girls; mean age, 7.3 +/- 0.3 yr), 14 of whom (10 boys and 4 girls) had Silver-Russell syndrome. The 24-h secretion of GH was compared with that in 2 reference populations of prepubertal children born at an appropriate size for gestational age (AGA): 179 short healthy children (143 boys and 36 girls; mean age, 10.2 +/- 0.2 yr) and 73 children of normal stature (54 boys and 19 girls; mean age, 10.4 +/- 0.3 yr). Plasma GH concentrations from the 24-h profiles were transformed to GH secretion rates by means of a deconvolution technique. For the SGA children, the mean GH secretion rate was 0.3 U/24 h, with a positive correlation with age, whereas for the reference groups it was higher, 0.5 U/24 h for the short children (P < 0.05) and 0.7 U/24 h for the children of normal stature (P < 0.001). Interestingly, the GH secretion rate correlated positively with weight for height, expressed as the SD score, in girls born SGA (r = 0.40; P < 0.05), whereas an inverse correlation was found for the short AGA girls (r = -0.44; P < 0.05). The mean baseline GH level in the SGA children correlated negatively with age (r = -0.53; P < 0.01), with the highest values found for children younger than 6 yr of age. On the average, 8 GH peaks/24-h period were found in all groups of children, and using Fourier time-series analyses, a similar rhythmicity was found in all groups. In the SGA group, the children younger than 6 yr of age had more GH peaks with lower amplitudes than the older children. It is concluded that children born SGA and still short at or after 2 yr of age spontaneously secrete less GH than healthy children of short stature born AGA. Both of these subgroups of prepubertal short children, however, secrete less GH than children of normal height. This finding might in part explain the growth failure in SGA children. Moreover, in the youngest SGA children (2-6 yr of age) there was another pattern of GH secretion, with a high basal GH level, a low peak amplitude, and a high peak frequency.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7673401     DOI: 10.1210/jcem.80.9.7673401

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Small for gestation and growth hormone therapy.

Authors:  Archana Dayal Arya
Journal:  Indian J Pediatr       Date:  2006-01       Impact factor: 1.967

Review 2.  Fetal origins of adult disease: a paediatric perspective.

Authors:  Harriet L Miles; Paul L Hofman; Wayne S Cutfield
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

3.  Prematurity and low birth weight lead to altered bone geometry, strength, and quality in children.

Authors:  S Longhi; F Mercolini; L Carloni; L Nguyen; A Fanolla; G Radetti
Journal:  J Endocrinol Invest       Date:  2014-12-25       Impact factor: 4.256

Review 4.  Efficacy and safety of growth hormone treatment for children born small for gestational age.

Authors:  Il Tae Hwang
Journal:  Korean J Pediatr       Date:  2014-09-30

5.  A case of Silver-Russell syndrome (SRS): multiple pituitary hormone deficiency, lack of H19 hypomethylation and favourable growth hormone (GH) treatment response.

Authors:  Zoran S Gucev; Velibor Tasic; Aleksandra Jancevska; Ilija Kirovski
Journal:  J Genet       Date:  2009-08       Impact factor: 1.166

Review 6.  Should recombinant human growth hormone therapy be used in short small for gestational age children?

Authors:  L B Johnston; M O Savage
Journal:  Arch Dis Child       Date:  2004-08       Impact factor: 3.791

Review 7.  Current Insights into the Role of the Growth Hormone-Insulin-Like Growth Factor System in Short Children Born Small for Gestational Age.

Authors:  Judith S Renes; Jaap van Doorn; Anita C S Hokken-Koelega
Journal:  Horm Res Paediatr       Date:  2019-09-11       Impact factor: 2.852

Review 8.  Growth hormone treatment in children: review of safety and efficacy.

Authors:  Mark Harris; Paul L Hofman; Wayne S Cutfield
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

9.  Comparative evaluation of short-term biomarker response to treatment for growth hormone deficiency in Chinese children with growth hormone deficiency born small for or appropriate for gestational age: a randomized phase IV open-label study.

Authors:  Wenli Lu; Shuixian Shen; Xiaoping Luo; Chunxiu Gong; Xuefan Gu; Yun Li; Minlian Du; Runming Jin; Queena Zhou; Wei Wang
Journal:  Ther Adv Endocrinol Metab       Date:  2013-04       Impact factor: 3.565

10.  IGF-I and IGF Binding Protein-3 Generation Tests and Response to Growth Hormone in Children with Silver-Russell Syndrome.

Authors:  Izabel C R Beserra; Márcia G Ribeiro; Paulo F Collett-Solberg; Mário Vaisman; Marília M Guimarães
Journal:  Int J Pediatr Endocrinol       Date:  2010-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.